Qiming Venture Partners announced the closing of Qiming Venture Partners Fund VII, a fund focused on early stage healthcare and technology, media and telecom investments.
The portfolio will center on areas such as biopharma, medtech, diagnostics, health care services, information technology, artificial intelligence, enterprise services, consumer internet and e-commerce.
Closing at $1.1 billion, the fund attracted capital from endowments, foundations, family offices and private pensions. Jim Millar, managing director at Princeton University Investment Company (PRINCO) said, "Qiming has developed a strong reputation and track record as a leading venture capital firm and is . . .
Unlock this article instantly, along with the rest of our premium content and benefits including daily/weekly/monthly newsletters.